{"id":941977,"date":"2026-03-04T09:34:42","date_gmt":"2026-03-04T14:34:42","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/mannkind-to-participate-in-upcoming-investor-conferences\/"},"modified":"2026-03-04T09:34:42","modified_gmt":"2026-03-04T14:34:42","slug":"mannkind-to-participate-in-upcoming-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/mannkind-to-participate-in-upcoming-investor-conferences\/","title":{"rendered":"MannKind to Participate in Upcoming Investor Conferences"},"content":{"rendered":"
\n

DANBURY, Conn.\u00a0and\u00a0WESTLAKE VILLAGE, Calif., March 04, 2026 (GLOBE NEWSWIRE) — MannKind Corporation\u00a0(Nasdaq: MNKD)<\/strong>, announced today its attendance at two upcoming investor conferences, at which MannKind\u2019s Chief Executive Officer, Michael Castagna, PharmD, and Chief Financial Officer,\u00a0Chris Prentiss\u00a0will participate in fireside chats and in 1×1 meetings with investors.<\/p>\n

\n Leerink Partners 2026 Global Healthcare Conference in Miami<\/strong>
\n
Tuesday, March 10, 3:40 p.m. ET<\/p>\n

\n Barclays 28<\/strong>
\n
\n th<\/strong>
\n <\/sup>
\n Annual Global Healthcare Conference in Miami<\/strong>
\n
Wednesday, March 11, 1:00 p.m. ET<\/p>\n

Links to the live audio webcast of the sessions will be available on MannKind Corporation\u2019s website at:\u00a0https:\/\/investors.mannkindcorp.com\/events-and-presentations<\/a>. Recorded versions will also be available on the website for approximately 90 days following the conference.<\/p>\n

\n About MannKind <\/strong>
\n
MannKind Corporation (Nasdaq: MNKD) is a biopharmaceutical company dedicated to transforming chronic disease care through innovative, patient-centric solutions. Focused on cardiometabolic and orphan lung diseases, we develop and commercialize treatments that address serious unmet medical needs, including diabetes, pulmonary hypertension, and fluid overload in heart failure and chronic kidney disease.<\/p>\n

With deep expertise in drug-device combinations, MannKind aims to deliver therapies designed to fit seamlessly into daily life.<\/p>\n

Learn more at mannkindcorp.com.<\/p>\n

Contacts:
Investor Relations
Kate Miranda
(617) 921-5461
Email: ir@mnkd.com<\/p>\n

Media Relations
Christie Iacangelo
(818) 292-3500
Email: media@mnkd.com<\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

DANBURY, Conn.\u00a0and\u00a0WESTLAKE VILLAGE, Calif., March 04, 2026 (GLOBE NEWSWIRE) — MannKind Corporation\u00a0(Nasdaq: MNKD), announced today its attendance at two upcoming investor conferences, at which MannKind\u2019s Chief Executive Officer, Michael Castagna, PharmD, and Chief Financial Officer,\u00a0Chris Prentiss\u00a0will participate in fireside chats and in 1×1 meetings with investors. Leerink Partners 2026 Global Healthcare Conference in Miami Tuesday, March 10, 3:40 p.m. ET Barclays 28 th Annual Global Healthcare Conference in Miami Wednesday, March 11, 1:00 p.m. ET Links to the live audio webcast of the sessions will be available on MannKind Corporation\u2019s website at:\u00a0https:\/\/investors.mannkindcorp.com\/events-and-presentations. Recorded versions will also be available on the website for approximately 90 days following the conference. About MannKind MannKind Corporation (Nasdaq: MNKD) is a biopharmaceutical company dedicated to … <\/p>\n

Continue reading “MannKind to Participate in Upcoming Investor Conferences”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-941977","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nMannKind to Participate in Upcoming Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/mannkind-to-participate-in-upcoming-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MannKind to Participate in Upcoming Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"DANBURY, Conn.\u00a0and\u00a0WESTLAKE VILLAGE, Calif., March 04, 2026 (GLOBE NEWSWIRE) — MannKind Corporation\u00a0(Nasdaq: MNKD), announced today its attendance at two upcoming investor conferences, at which MannKind\u2019s Chief Executive Officer, Michael Castagna, PharmD, and Chief Financial Officer,\u00a0Chris Prentiss\u00a0will participate in fireside chats and in 1×1 meetings with investors. Leerink Partners 2026 Global Healthcare Conference in Miami Tuesday, March 10, 3:40 p.m. ET Barclays 28 th Annual Global Healthcare Conference in Miami Wednesday, March 11, 1:00 p.m. ET Links to the live audio webcast of the sessions will be available on MannKind Corporation\u2019s website at:\u00a0https:\/\/investors.mannkindcorp.com\/events-and-presentations. Recorded versions will also be available on the website for approximately 90 days following the conference. About MannKind MannKind Corporation (Nasdaq: MNKD) is a biopharmaceutical company dedicated to … Continue reading "MannKind to Participate in Upcoming Investor Conferences"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/mannkind-to-participate-in-upcoming-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-03-04T14:34:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY2NTQ5MCM3NDY2NjMwIzIwMDgxMDc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mannkind-to-participate-in-upcoming-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mannkind-to-participate-in-upcoming-investor-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"MannKind to Participate in Upcoming Investor Conferences\",\"datePublished\":\"2026-03-04T14:34:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mannkind-to-participate-in-upcoming-investor-conferences\\\/\"},\"wordCount\":214,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mannkind-to-participate-in-upcoming-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY2NTQ5MCM3NDY2NjMwIzIwMDgxMDc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mannkind-to-participate-in-upcoming-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mannkind-to-participate-in-upcoming-investor-conferences\\\/\",\"name\":\"MannKind to Participate in Upcoming Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mannkind-to-participate-in-upcoming-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mannkind-to-participate-in-upcoming-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY2NTQ5MCM3NDY2NjMwIzIwMDgxMDc=\",\"datePublished\":\"2026-03-04T14:34:42+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mannkind-to-participate-in-upcoming-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mannkind-to-participate-in-upcoming-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mannkind-to-participate-in-upcoming-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY2NTQ5MCM3NDY2NjMwIzIwMDgxMDc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY2NTQ5MCM3NDY2NjMwIzIwMDgxMDc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mannkind-to-participate-in-upcoming-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MannKind to Participate in Upcoming Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"MannKind to Participate in Upcoming Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/mannkind-to-participate-in-upcoming-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"MannKind to Participate in Upcoming Investor Conferences - Market Newsdesk","og_description":"DANBURY, Conn.\u00a0and\u00a0WESTLAKE VILLAGE, Calif., March 04, 2026 (GLOBE NEWSWIRE) — MannKind Corporation\u00a0(Nasdaq: MNKD), announced today its attendance at two upcoming investor conferences, at which MannKind\u2019s Chief Executive Officer, Michael Castagna, PharmD, and Chief Financial Officer,\u00a0Chris Prentiss\u00a0will participate in fireside chats and in 1×1 meetings with investors. Leerink Partners 2026 Global Healthcare Conference in Miami Tuesday, March 10, 3:40 p.m. ET Barclays 28 th Annual Global Healthcare Conference in Miami Wednesday, March 11, 1:00 p.m. ET Links to the live audio webcast of the sessions will be available on MannKind Corporation\u2019s website at:\u00a0https:\/\/investors.mannkindcorp.com\/events-and-presentations. Recorded versions will also be available on the website for approximately 90 days following the conference. About MannKind MannKind Corporation (Nasdaq: MNKD) is a biopharmaceutical company dedicated to … Continue reading \"MannKind to Participate in Upcoming Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/mannkind-to-participate-in-upcoming-investor-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2026-03-04T14:34:42+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY2NTQ5MCM3NDY2NjMwIzIwMDgxMDc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mannkind-to-participate-in-upcoming-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mannkind-to-participate-in-upcoming-investor-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"MannKind to Participate in Upcoming Investor Conferences","datePublished":"2026-03-04T14:34:42+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mannkind-to-participate-in-upcoming-investor-conferences\/"},"wordCount":214,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mannkind-to-participate-in-upcoming-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY2NTQ5MCM3NDY2NjMwIzIwMDgxMDc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mannkind-to-participate-in-upcoming-investor-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/mannkind-to-participate-in-upcoming-investor-conferences\/","name":"MannKind to Participate in Upcoming Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mannkind-to-participate-in-upcoming-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mannkind-to-participate-in-upcoming-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY2NTQ5MCM3NDY2NjMwIzIwMDgxMDc=","datePublished":"2026-03-04T14:34:42+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mannkind-to-participate-in-upcoming-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/mannkind-to-participate-in-upcoming-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mannkind-to-participate-in-upcoming-investor-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY2NTQ5MCM3NDY2NjMwIzIwMDgxMDc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY2NTQ5MCM3NDY2NjMwIzIwMDgxMDc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mannkind-to-participate-in-upcoming-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"MannKind to Participate in Upcoming Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/941977","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=941977"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/941977\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=941977"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=941977"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=941977"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}